Table of Content - Gemigliptin Market

Gemigliptin is a potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor used in the management of type 2 diabetes mellitus. With its unique chemical structure, gemigliptin effectively lowers blood glucose levels by enhancing the action of incretin hormones. This oral medication offers promising results in gycemic control by promoting glucose-dependent insulin secretion and suppressing glucagon release. As a newer entrant in the DPP-4 inhibitor class, Gemigliptin’s safety profile and efficacy make it a valuable option for diabetes patients seeking improved glucose regulation and a reduced risk of hypoglycaemia. This medication is characterized by its unique chemical structure and mechanism of action, setting it apart from other antidiabetic drugs. Gemigliptin is typically prescribed as a once-daily oral treatment, providing convenience for patients managing their diabetes. However, ongoing research, strategic marketing, and potential innovations in formulation or combination therapies aim to position gemigliptin as a valuable option in the diverse landscape of diabetes management.

Market Dynamics:

The rising prevalence of diabetes, increasing awareness and diagnosis, and shift towards oral antidiabetic drugs are anticipated to drive growth of the global gemigliptin market over the forecast period. Moreover, a favorable regulatory environment is also expected to boost the growth of the global gemigliptin market over the forecast period. Expansion in emerging markets, combination therapies, a focus on patient-centric approaches, pediatric use, and gestational diabetes are expected to create growth opportunities for the global gemigliptin market during the forecast period.

However, competition from established drugs, patent expiry, generic competition, and safety concerns are expected to hamper growth of the gemigliptin market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the gemigliptin market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the gemigliptin market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Daewoong Pharmaceutical, Sanofi, LG Chem, Hanmi Pharmaceutical Co., Ltd., and Merck
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The gemigliptin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the gemigliptin market

Detailed Segmentation:

Gemigliptin Market Segmentation, By Type of Drug:
- Gemigliptin Monotherapy
- Gemigliptin Combination Therapy
Gemigliptin Market Segmentation, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Gemigliptin Market Segmentation, By End User:
- Hospitals
- Clinics and Outpatient Facilities
- Others (Academic and Research Institutes)
Gemigliptin Market Segmentation, By Patient Demographics:
- Adult Population
- Geriatric Population
Gemigliptin Market Segmentation, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profile:
- Daewoong Pharmaceutical
- Sanofi
- LG Chem
- Hanmi Pharmaceutical Co., Ltd.
- Merck

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Gemigliptin , By Type of Drug
  - Market Gemigliptin , By Distribution Channel
  - Market Gemigliptin , By End User
  - Market Gemigliptin , By Patient Demographics
  - Market Gemigliptin , By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
    - Rising prevalence of diabetes
  - Restraints
    - Competition from established drugs
  - Opportunities
    - Expansion in emerging markets
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
Gemigliptin Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
Gemigliptin Market , By Type of Drug, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019-2030
  - Segment Trends
- Gemigliptin Monotherapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Gemigliptin Combination Therapy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Gemigliptin Market , By Distribution Channel, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019-2030
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Gemigliptin Market , By End User, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019-2030
  - Segment Trends
- Hospitals
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Retail Clinics and Outpatient Facilities
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Others (Academic and Research Institutes)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Gemigliptin Market , By Patient Demographics, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2019-2030
  - Segment Trends
- Adult Population
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
- Geriatric Population
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Gemigliptin Market , By Region, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, By Country, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, For Country 2019-2030
  - Country Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type of Drug, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Patient Denographics, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type of Drug, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Patient Denographics, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type of Drug, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Patient Denographics, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type of Drug, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Patient Denographics, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type of Drug, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Patient Denographics, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type of Drug, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Patient Denographics, 2018-2030,(US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030, (US$ Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Daewoong Pharmaceutical
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- LG Chem
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Hanmi Pharmaceutical Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Merck
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Analyst Views
Section
- Research Methodology
- About us

*Browse 24 market data tables and 28 figures on "Gemigliptin Market” - Global forecast to 2030

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount